Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study proposes to recruit patients with Opioid Use Disorder (OUD) seeking treatment into our program of outpatient detoxification and naltrexone induction followed by a relapse-prevention treatment with Extended release-naltrexone (XR-NTX) . Eligible participants will be randomly assigned to adjunctive treatment with lorcaserin (N = 40), or placebo (N = 20) with weekly therapy.
Epistemonikos ID: 1365a985d9b15850da3ffc837f8ba44a84d2a69b
First added on: May 20, 2024